Australian Biotechnology News

Stories about: IMS

  • +

    Feature: Automating the personalised medicine revolution 10/08/2010 17:32:00

    Processing large numbers of samples rapidly is going to be crucial if the vision of personalised medicine is ever going to become a reality.
  • +

    Life sciences ripe for IT explosion: analysts 23/03/2010 10:29:00

    Life science sector lagging behind in adoption of IT, representing a $17 billion opportunity for IT providers.
  • +

    Psivida closer to Nasdaq listing 20/01/2005 14:24:59

    Nanotechnology company Psivida (ASX:PSD) is to join a small band of Australian biotechs on the US Nasdaq market, announcing today it had filed a registration statement with the US Securities and Exchange Commission in relation to its planned listing of American Depositary Shares (ADSs).
  • +

    Third-quarter results highlight big pharma's ills 25/10/2004 14:45:14

    Big pharma looks sick. A host of third-quarter earnings figures this week confirms the mounting pressures faced by many drug makers on both sides of the Atlantic as prices are squeezed, sales growth in major markets slows and research productivity falls.
  • +

    Biota wins access to GSK documents 11/08/2004 15:12:20

    An affidavit filed on behalf of Biota (ASX: BTA) in the Victorian Supreme Court this week has shown that the amount of money spent by GlaxoSmithKline in promoting Biota's drug Relenza in major markets dropped by 80 per cent in the second flu season after the drug was approved.
  • +

    Japanese SNP project releases data 08/11/2002 16:37:30

    The number of SNPs (single nucleotide polymorphisms) discovered by Japan Science and Technology Corp (JST) and Tokyo University's Institute of Medical Science, in an initiative that is part of the government-driven Millennium Project, has risen to 193,037, according to recently published data.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Jobs